RxDoctor Payments Data

Mohammed Ahmed, MD

Psychiatry · Houston, TXNPI 1255695532

Payments from drug & device makers

$1,132in general payments, 2019–2025

Across 48 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$277
  • Lundbeck LLC$198
  • Otsuka America Pharmaceutical, Inc.$197
  • Tris Pharma Inc$67
  • Neuronetics, Inc.$62
  • Harmony Biosciences LLC$60
  • plus $272 from 7 others

What the payments were for

  • Food & beverage$1,132100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,132 in reported general payments places this provider in the 70th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$12,195
Medicare patients
33
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole32$85,057
VraylarCariprazine Hcl20$26,518
Lurasidone Hcl53$18,862
Aripiprazole113$11,516
VyvanseLisdexamfetamine Dimesylate26$10,324
Duloxetine Hcl191$9,590
Quetiapine Fumarate375$7,909
TrintellixVortioxetine Hydrobromide13$5,988
Paliperidone ErPaliperidone18$3,017
Trazodone Hcl360$2,646
Haloperidol Decanoate50$2,508
Olanzapine24$2,330
Hydroxyzine Hcl101$2,097
Divalproex Sodium ErDivalproex Sodium13$2,030
Sertraline Hcl309$1,778

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$197$85,05732 claims
AbbVieVraylar$52$26,51820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →